Company Filing History:
Years Active: 2015-2023
Title: Innovations in Immunology: The Contributions of Elizabeth R. Mann
Introduction
Elizabeth R. Mann, an esteemed inventor based in Germantown, TN, has made significant strides in the field of immunology. With a focus on the prevention and treatment of bacterial infections, particularly pneumococcal infections, her work has led to the development of innovative methods and compositions that utilize immunogenic fusion proteins. Through her dedication and expertise, she has been granted three patents that underscore her commitment to advancing medical science.
Latest Patents
Elizabeth R. Mann's latest patents involve innovative methods and compositions that target bacterial infections. The compositions include a variety of immunogenic fusion proteins, which incorporate key components such as CbpA polypeptides and cytolysins. These inventions offer promising avenues for both the prevention and treatment of infections caused by bacteria, particularly focusing on pneumococcal infections. The detailed methodologies provided in her patents outline the efficacy of these proteins in combating such health issues.
Career Highlights
Elizabeth R. Mann is currently affiliated with St. Jude Children's Research Hospital, a renowned institution dedicated to pediatric healthcare and research. Her role at this esteemed hospital allows her to collaborate closely with other experts in the field, pushing the boundaries of what is possible in medical innovation. Throughout her career, Mann has been recognized for her contributions to health science, particularly in the domain of infectious diseases.
Collaborations
A significant aspect of Elizabeth R. Mann's work is her collaboration with Elaine I. Tuomanen, another prominent figure in the field of immunology. Together, they have explored various methodologies and innovations that enhance the understanding and treatment of bacterial infections. Their combined efforts have led to groundbreaking advancements in immunogenic research, positioning them as leaders in their field.
Conclusion
Elizabeth R. Mann stands out as a pioneering inventor whose contributions to immunology have the potential to save lives and improve healthcare outcomes. Through her patents and collaborations, she continues to drive innovation in the prevention and treatment of bacterial infections. As the field of medical research progresses, her work will undoubtedly play a pivotal role in shaping future therapies and interventions.